Clinical Trial Update: Effect of Flozin (dapagliflozin) Administration on Myocardial and Peripheral Vascular Remodeling

View source ↗

Summary

An update on a clinical trial evaluating the effects of dapagliflozin (Flozin) on myocardial and peripheral vascular remodeling in heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Flozin (dapagliflozin) (dapagliflozin)

Snippet

Sponsor: Poznan University of Medical Sciences | Conditions: Heart Failure | Status: UNKNOWN